Terraflos Inc.

What Terraflos Inc. does

Terraflos Inc. is a Uruguay-headquartered Consumer Science Company founded in 2020 that combines cellular agriculture, synthetic biology, and proprietary AI to discover, scale, and commercialize plant-based bioactives for the wellness and longevity market. The company operates a vertically integrated stack spanning B2B R&D/CDMO services through subsidiaries Rubisco (biotech), Blueberries Medical, Caliz.Bio, and KBG, and B2C consumer brands including Vitalis Navitas (personalized and standardized supplements), Nutri Co (plant-based functional foods marketed as 'Hyperfoods'), and Bioderm (dermocosmetics in development). Its flagship bioactive, Australcell™ Alerce, is produced from Fitzroya cupressoides (Patagonian Alerce) cells without traditional agriculture and is protected by international patent WO2020075074; preclinical and clinical data claim 46.28% antioxidant activity, 74.71% hyaluronidase inhibition, and 270% greater efficacy versus placebo in a 22-person human trial. A proprietary Agentic AI system called JEN coordinates operations across the subsidiary network, while 'Virtual Cells' AI models simulate cellular behavior for bioactive discovery and formulation optimization.

The business model is hybrid: B2C revenue flows through e-commerce platforms (vitalisnavitas.com, nutrico.io) and retail distribution via the branded subsidiaries — including subscription-based personalized supplements and one-off packaged functional food SKUs — while B2B revenue comes from licensing proprietary bioactives and providing R&D and CDMO services to third-party brands, laboratories, and cosmetic companies. The company reports serving health-conscious consumers seeking longevity and personalized wellness in Latin America, with documented traction including Vitalis Navitas reaching top supplement brand status in Argentina within four years. Production is positioned around sustainability claims of 99% water reduction, 75% lower CO2 emissions, and elimination of soil degradation versus conventional bioactive sourcing. Capital deployment has supported geographic expansion into Argentina, Mexico, and Brazil, with a partnership with Colombian Nutripharma opening the Andean corridor.

The firm is venture-backed, having raised approximately $8M across disclosed rounds from Aerolab Ventures, FL Ventures, Morgenthaler Private Equity, and Yaax Capital, with an advisory board drawing GPs from multiple regional VCs (NXTP Ventures, Newtopia VC, Think VC, Rainforest Capital, White Lions VC, ATW Partners, Infinity Group). The company reports a 51–100 employee base, projected ~87% CAGR from a sub-$1M first-year revenue base, and is targeting $15M in projected annual revenue. All financial and growth figures stated above are company-projected rather than independently audited, which is a material caveat for diligence.

Name

Terraflos Inc.

Legal name

Terraflos Inc.

Website

https://terraflos.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Terraflos Inc. is a Uruguay-based Consumer Science Company that uses cellular agriculture, synthetic biology, and proprietary AI (JEN, Virtual Cells) to discover and commercialize plant-based bioactives across B2C supplement and functional-food brands (Vitalis Navitas, Nutri Co, Bioderm) and B2B ingredient licensing and CDMO services targeting Latin American health, wellness, and longevity markets.

Ownership category

akta.pro rank

Product category

Biotechnology & Bioactive Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Plant-Based & Alternative Proteins (Packaged) (CRADAAAH)

Keywords

• Cellular agriculture
• Bioactive ingredients
• Plant-based supplements
• Functional foods
• Synthetic biology

Headquarters

HQ city

Montevideo

HQ country

Uruguay

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. B2C Consumer Products: Sale of supplements (Vitalis Navitas), functional foods (Nutri Co), and dermocosmetics (Bioderm) directly to consumers through e-commerce platforms and retail channels. Subscription model for personalized supplements.
2. B2B Bioactive Ingredients: Licensing and sale of proprietary bioactive ingredients (like Australcell™ Alerce) and scientific solutions to third-party brands, laboratories, and cosmetic companies. CDMO services for research and development.
3. R&D and CDMO Services: Research and development services for bioactive discovery, scaling, and transformation for the health and wellness industry through B2B subsidiaries.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Terraflos discovers, scales, and transforms plant-derived bioactives through cellular agriculture and synthetic biology into functional products. It operates B2C consumer brands (Vitalis Navitas supplements, Nutri Co functional foods, Bioderm dermocosmetics) sold via e-commerce and retail, and B2B subsidiaries (Rubisco, Blueberries Medical, Caliz.Bio, KBG) that license patented bioactives such as Australcell™ Alerce and provide R&D and contract development manufacturing services to the health and wellness industry. Its proprietary JEN Agentic AI and Virtual Cells models orchestrate product development and personalization.

Product overview

Terraflos Inc. is a Consumer Science Company that operates as a multi-brand platform with both B2C and B2B business units. The B2C portfolio includes two main consumer brands: Vitalis Navitas (supplements with AI-powered 100% personalization platform, plus standardized products like Collagen Beauty and Omega 3) and Nutri Co (hyperfoods/superfoods including Protein Prebiotic Bars, Piqueos Crunch, and Quinoa Cookies). A third B2C segment called Bioderm (SkinTech) is in development. The B2B infrastructure includes Rubisco (biotechnology core producing patented bioactives like Australcell™ Alerce), Blueberries Medical, Caliz.Bio, and KBG — all focused on bioactive discovery and CDMO services. The company also developed JEN, a proprietary Agentic AI that coordinates its network-of-teams structure. Products span supplements, functional foods, and dermocosmetics, all powered by AI-driven product development and cellular agriculture technology.

Differentiator

Problem solved

Functional benefit

Brands

• Wellgevity: Supplements brand focused on longevity and wellness products
• Hyperfood
• Bioderm
• Nutri Co
• Vitalis Navitas
• Rubisco
• Blueberries
• Caliz.Bio
• KBG
• JEN

Products and services

• Vitalis Navitas Supplements B2C nutritional supplement brand under Terraflos promoting health and wellness through products that fuse science and nature. Includes standardized SKUs (e.g., Vitalis Collagen Beauty with PEPTAN, Omega 3 EPA 450-DHA) and AI-personalized supplements using genetics and biomarkers. Targeted at health-conscious consumers in Latin America, primarily Argentina.
• Nutri Co Functional Foods Foodtech subsidiary developing accessible 100% plant-based superfoods (hyperfoods) using AI and scientific evidence. Products include Protein Prebiotic Bars, Piqueos Crunch snacks, and Quinoa Cookies with cocoa nibs. Positioned as 200% more nutritious than average functional foods, with -63% land, -90% water, -75% energy, and -75% CO2 footprint. Sold via nutrico.io e-commerce.
• Bioderm Dermocosmetics B2C dermocosmetics brand in Terraflos' SkinTech segment focused on skin longevity. Integrates patented bioactive ingredients including Australcell™ Alerce for skincare applications. Targeted at health-conscious consumers seeking science-backed skincare.
• Australcell™ Alerce Bioactive Ingredient Patent-protected bioactive ingredient derived from Patagonian Alerce (Fitzroya cupressoides) cells using cellular agriculture. Demonstrated 46.28% global antioxidant activity, 74.71% hyaluronidase inhibition, and 28.39% collagenase inhibition in preclinical trials, with 270% greater efficacy than placebo in n=22 human clinical trials over 30 days of topical application. Licensed to third-party brands, laboratories, and cosmetic companies.
• Bioactive Ingredient Portfolio Portfolio of high-precision bioactives sourced from Latin American biodiversity including Olea europaea (olive), Artemisia vulgaris (mugwort), Chenopodium quinoa (quinoa peptide), Centella asiatica, Rheum rhabarbarum (rhubarb), Rosa rubiginosa (rosehip), Moringa oleifera, Argania spinosa (argan), Quillaja saponaria, Azadirachta indica (neem), Aristotelia chilensis (maqui), Cannabis, and Fitzroya cupressoides (alerce). Licensed and sold to third-party brands and laboratories.
• B2B R&D and CDMO Services Research, development, and contract development manufacturing (CDMO) services for bioactive discovery, scaling, and transformation, sold to third-party brands, laboratories, and cosmetic companies in the health and wellness industry. Delivered through Terraflos' subsidiary network (Rubisco, Blueberries Medical, Caliz.Bio, KBG).

Quantifiable outcome

• Australcell™ Alerce demonstrated 270% greater efficacy than placebo in clinical trials (n=22, 30 days topical application)
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Partnerships

One partnership is on record.

• Nutripharma (Colombia)coreStrategic or Co-development Partner · 28 August 2023Terraflos announced partnership with Colombian Nutripharma for expansion purposes. Grupo uruguayo Terraflos announced its association with the Colombian company Nutripharma as part of their Latin American expansion strategy into Colombia and neighboring markets.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Ginkgo Bioworks: Cellular engineering platform serving industries from food to pharma. Comparable as a much larger incumbent in the same cellular agriculture / synthetic biology infrastructure space that powers Terraflos's bioactive production.
• Codexis: Synthetic biology and enzyme engineering company serving pharmaceutical and food ingredient customers. Broad incumbent peer for Terraflos's biotech discovery and scale-up capabilities within Rubisco.

Direct peers

• Conagen: Biotech using precision fermentation to produce sustainable bioactives, flavors, and ingredients for supplements and cosmetics. Closely comparable technology stack and B2B ingredient licensing model to Terraflos's Rubisco.
• Care/of: DTC personalized vitamin and supplement company using a questionnaire-driven recommendation engine. Direct comparable to Vitalis Navitas's AI-powered personalized supplements offering, both targeting health-conscious consumers via subscription.
• Amyris: Synthetic biology company that engineered microbes to produce high-value bioactives (squalane, terpenes) for cosmetics and supplements. Directly comparable to Terraflos's Rubisco biotech platform and Australcell™ Alerce bioactive commercialization model.
• Perfect Day: Cellular agriculture company producing animal-free dairy proteins via fermentation. Directly comparable for its cellular agriculture production model and B2B ingredient commercialization into CPG brands, mirroring Terraflos's Rubisco-to-consumer pipeline.
• NotCo: LATAM-based AI-driven plant-based foodtech (Giuseppe AI) producing dairy and meat alternatives. Direct regional peer to Nutri Co, both using proprietary AI for plant-based product development and pursuing sustainability-led functional food positioning.
• Ritual: Science-led, DTC supplement brand focused on traceability and clean ingredients. Closely comparable to Vitalis Navitas in brand positioning, science-backed storytelling, and premium DTC supplement distribution.
• Geltor: Cellular agriculture company producing animal-free bioactive proteins (collagen, elastin) for cosmetics and supplements. Direct comparable for cellular agriculture bioactives serving the same dermocosmetics and wellness customer base as Australcell™ Alerce and Bioderm.
• Persona Nutrition: Personalized vitamin subscription brand using individual health profiles to tailor packs. Directly comparable to Vitalis Navitas's biomarker/genetics-driven personalized supplement platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/terraflos
• Instagraminstagram.com/terraflosok
• Xx.com/terraflosok

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terraflos Inc.